In a filing, Nurix Therapeutics Inc revealed its Chief Legal Officer Ring Christine unloaded Company’s shares for reported $0.14 million on Nov 01 ’24. In the deal valued at $24.28 per share,5,760 shares were sold. As a result of this transaction, Ring Christine now holds 28,084 shares worth roughly $0.69 million.
Then, van Houte Hans sold 3,546 shares, generating $86,083 in total proceeds. Upon selling the shares at $24.28, the Chief Financial Officer now owns 33,724 shares.
Before that, JOHANNES VAN HOUTE bought 3,546 shares. Nurix Therapeutics Inc shares valued at $87,161 were divested by the Officer at a price of $24.58 per share.
UBS initiated its Nurix Therapeutics Inc [NRIX] rating to a Buy in a research note published on October 24, 2024; the price target was $35. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Truist started covering the stock on July 31, 2024. It rated NRIX as “a Buy”.
Price Performance Review of NRIX
On Friday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock fall -0.45% to $24.47. Over the last five days, the stock has lost -6.85%. Nurix Therapeutics Inc shares have risen nearly 137.11% since the year began. Nevertheless, the stocks have risen 332.33% over the past one year. While a 52-week high of $27.60 was reached on 10/28/24, a 52-week low of $4.96 was recorded on 01/29/24. SMA at 50 days reached $24.20, while 200 days put it at $17.75.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 24.02, which if violated will result in even more drops to 23.56. On the upside, there is a resistance level at 24.84. A further resistance level may holdings at 25.21. The Relative Strength Index (RSI) on the 14-day chart is 50.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.53%. Stochastics %K at 27.19% indicates the stock is a holding.
How much short interest is there in Nurix Therapeutics Inc?
A steep rise in short interest was recorded in Nurix Therapeutics Inc stocks on 2024-10-15, dropping by -0.12 million shares to a total of 9.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 9.36 million shares. There was a decline of -1.34%, which implies that there is a negative sentiment for the stock.